Dresner Partners Advised JADE Biomedical (China) on Investment by and Partnership with Charles River Labs

Dresner Partners Advised JADE Biomedical (China) on Investment by and Partnership with Charles River Labs Published 17 Feb 2021 SILICON VALLEY, Calif. and SHANGHAI, China, Feb. 17, 2021 (GLOBE NEWSWIRE) — Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised JADE Biomedicalâ„¢ of China (JADE). Charles River Laboratories (CRL) has made an equity investment in JADE and formed a strategic business partnership to expand worldwide joint biologics quality and clinical testing capabilities.JADE is a provider of end-to-end quality management services for the biopharmaceutical industry. The partnership will expand CRL's…